Literature DB >> 14699137

Inhibition of human p53 basal transcription by down-regulation of protein kinase Cdelta.

Tarek Abbas1, David White, Li Hui, Kiyotsugu Yoshida, David A Foster, Jill Bargonetti.   

Abstract

In response to DNA damage, signal transduction pathways are activated that result in the increase of p53 protein levels, leading to either growth arrest or apoptosis. Protein kinase C (PKC) delta has been implicated as a tumor suppressor that is down-regulated by tumor-promoting phorbol esters in both mouse skin and cell culture models. We report here that the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate prevents DNA damage-induced up-regulation of p53 by down-regulating PKC delta. Regulation of p53 in response to stress most commonly occurs by preventing ubiquitination and degradation of the p53 protein. Surprisingly, suppression of p53 expression by inhibition of PKC delta was caused by the inhibition of p53 synthesis, not increased degradation of p53 protein. Inhibiting PKC delta blocked both basal transcription of the human p53 gene and initiation of transcription from the human p53 promoter. Therefore, the tumor-suppressing effects of PKC delta are mediated at least in part through activating p53 transcription.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14699137     DOI: 10.1074/jbc.M306979200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Alterations in protein kinase C activity and processing during zinc-deficiency-induced cell death.

Authors:  Susan S Chou; Michael S Clegg; Tony Y Momma; Brad J Niles; Jodie Y Duffy; George P Daston; Carl L Keen
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

2.  Use of a novel method to find substrates of protein kinase C delta identifies M2 pyruvate kinase.

Authors:  Stefan Siwko; Daria Mochly-Rosen
Journal:  Int J Biochem Cell Biol       Date:  2007-01-24       Impact factor: 5.085

3.  PKCdelta-mediated regulation of FLIP expression in human colon cancer cells.

Authors:  Qingding Wang; Xiaofu Wang; Yuning Zhou; B Mark Evers
Journal:  Int J Cancer       Date:  2006-01-15       Impact factor: 7.396

4.  Protein kinase C delta is required for survival of cells expressing activated p21RAS.

Authors:  Shuhua Xia; Lora W Forman; Douglas V Faller
Journal:  J Biol Chem       Date:  2007-03-08       Impact factor: 5.157

Review 5.  Distinctive activation mechanisms and functions for protein kinase Cdelta.

Authors:  Susan F Steinberg
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

6.  Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.

Authors:  Corina E Antal; Andrew M Hudson; Emily Kang; Ciro Zanca; Christopher Wirth; Natalie L Stephenson; Eleanor W Trotter; Lisa L Gallegos; Crispin J Miller; Frank B Furnari; Tony Hunter; John Brognard; Alexandra C Newton
Journal:  Cell       Date:  2015-01-22       Impact factor: 41.582

7.  Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion.

Authors:  Shabirul Haque; Xiao Jie Yan; Lisa Rosen; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  FASEB J       Date:  2013-10-21       Impact factor: 5.191

Review 8.  Regulating the activity of class II transactivator by posttranslational modifications: exploring the possibilities.

Authors:  Xiaoyan Wu; Xiaocen Kong; Larry Luchsinger; Barbara D Smith; Yong Xu
Journal:  Mol Cell Biol       Date:  2009-08-31       Impact factor: 4.272

9.  The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity.

Authors:  Elisabeth Ersvaer; Astrid Olsnes Kittang; Peter Hampson; Kristoffer Sand; Bjørn Tore Gjertsen; Janet M Lord; Oystein Bruserud
Journal:  Toxins (Basel)       Date:  2010-01-22       Impact factor: 4.546

10.  YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene Expression.

Authors:  Joyce Wu; Anna L Stratford; Arezoo Astanehe; Sandra E Dunn
Journal:  Transl Oncogenomics       Date:  2007-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.